NCT00726466View on ClinicalTrials.gov

Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2008

Conditions
Age Related Macular DegenerationAMDCNV
Interventions
DRUG

Efalizumab, Ranibizumab

Trial Locations (1)

10022

Vitreous Retina Macula Consultants of New York, New York

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

Vitreous -Retina- Macula Consultants of New York

OTHER

NCT00726466 - Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration | Biotech Hunter | Biotech Hunter